|
NGNE Neurogene Inc 1404644 |
| Balance Sheet |
|
Current Assets
|
143,647,000 |
|
Assets
|
164,120,000 |
|
Current Liabilities
|
15,800,000 |
|
Liabilities
|
26,706,000 |
|
Equity
|
137,414,000 |
|
Shares Out
|
12,994,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-53,107,000 |
|
Investing Cash Flow
|
-22,645,000 |
| Market Analysis |
Market Cap
|
685,737,787 |
|
Price
|
16.60 |
|
BVPS
|
10.58 |
|
PB
|
1.57 |
|
EPS
|
-4.93 |
|
PS
|
0.23 |
|
FCF
|
-75,752,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NGNE documents filed with the SEC.
NGNE Filings
Clear
